Top Markets
Coin of the day
ProUroCare Medical Inc. ProUroCare Medical Inc.

ProUroCare Medical Inc.

PUMD
Rank in Stocks #42361
ProUroCare Medical Inc. is dedicated to developing advanced products for the... ProUroCare Medical Inc. is dedicated to developing advanced products for the accurate identification and detailed assessment of male prostate diseases. The company's primary offering is the ProUroScan System, an innovative prostate imaging solution. This system empowers physicians to precisely document prostate irregularities that have been initially discovered through a digital rectal examination. ProUroCare has entered into strategic agreements with Artann Laboratories Inc., covering the licensing, ongoing development, and market commercialization of its ProUroScan System. The company was established in 1999 and is headquartered in Eden Prairie, Minnesota.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$1.86K
Change (1 day)
0.00%
Change (1 year)
-50.00%
Country
US
Trade ProUroCare Medical Inc. (PUMD)

Category

P/S ratio for ProUroCare Medical Inc. (PUMD)
P/S ratio as of 2026 TTM: 0
According to ProUroCare Medical Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for ProUroCare Medical Inc. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
3.95 -
US
4.83 -
US
2.78 -
IE
3.31 -
US
7.61 -
US